John Zhong Xie
Ophthalmology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 35
- 10 carriers
- Office
- 1
Offices
1 location · Advanced Eye Associates · 3 clinicians in this group
Looking this up.
Plans that list them
35 plans · 10 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call John Zhong Xie’s office at (408) 923-8138 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
35 of 35 plans
| Aetna Medicare Eagle (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Aetna Medicare Enhanced (PPO) | Aetna Medicare | Listed | Sep 8, 2026 |
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Original Medicare doctor bills
$141,151
Medicare paid this office $141,151 for 641 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Established patient problem focused exam of visual system | 357 | $41,921 | $77 |
| Established patient complete exam of visual system | 281 | $29,971 | $100 |
| Removal of cataract with insertion of prosthetic lens | 37 | $24,856 | $507 |
| Closure of tear duct opening using plug | 22 | $8,351 | $199 |
| New patient complete exam of visual system | 76 | $7,689 | $101 |
See all 13 services
| Established patient problem focused exam of visual system | 357 | $41,921 | $77 |
| Established patient complete exam of visual system | 281 | $29,971 | $100 |
| Removal of cataract with insertion of prosthetic lens | 37 | $24,856 | $507 |
| Closure of tear duct opening using plug | 22 | $8,351 | $199 |
| New patient complete exam of visual system | 76 | $7,689 | $101 |
| Imaging of retina | 118 | $5,104 | $32 |
| Exam of visual field with extended testing | 84 | $3,907 | $47 |
| Imaging of optic nerve | 101 | $2,606 | $26 |
| Short return visit (20+ min) | 67 | $1,827 | $26 |
| Measurement of corneal curvature and depth of eye | 43 | $1,561 | $35 |
| Removal of eyelashes using forceps | 32 | $1,497 | $18 |
| Return visit (30+ min) | 16 | $360 | $23 |
| Measurement of corneal curvature and depth of eye | 11 | $318 | $29 |
Procedures Medicare counted
| Cataract surgery | 48 | More than 63% of doctors who do this |
Who their Medicare patients are
641 Original Medicare patients in 2024. Average age 77 · Under 65 3% · 85 and older 18% · Women 65% · Also on Medicaid 80% · Health risk score 1.16. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 75% · Diabetes 55% · Chronic kidney disease 25% · Coronary heart disease 18% · Atrial fibrillation 12% · Heart failure 9% · Cancer 9% · COPD 9% · Depression 8% · Dementia 7% · Stroke 5%.
The office billed $440,840, Medicare allowed $219,968 and paid $141,151; for 1,615 services of 24 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 641 | 1,615 | 77 | 1.16 | $440,840 | $141,151 |
| 2023 | 761 | 2,010 | 77 | 1.22 | $524,524 | $162,790 |
| 2022 | 861 | 2,505 | 76 | 1.21 | $687,509 | $201,496 |
| 2021 | 622 | 1,991 | 75 | 1.31 | $657,558 | $212,690 |
| 2020 | 499 | 1,396 | 75 | 1.38 | $363,316 | $113,196 |
| 2019 | 937 | 2,695 | 75 | 1.44 | $731,947 | $247,212 |
| 2018 | 1,014 | 2,678 | 75 | 1.41 | $839,258 | $268,061 |
| 2017 | 1,002 | 2,149 | 75 | 1.36 | $588,073 | $204,458 |
| 2016 | 536 | 1,017 | 74 | 1.30 | $229,665 | $97,471 |
| 2015 | 309 | 488 | 74 | 1.34 | $122,227 | $56,609 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Established patient problem focused exam of visual system | 440 | $49,222 | $73 |
| Established patient complete exam of visual system | 350 | $36,734 | $94 |
| Removal of cataract with insertion of prosthetic lens | 28 | $21,738 | $518 |
| New patient complete exam of visual system | 129 | $12,010 | $93 |
| Closure of tear duct opening using plug | 24 | $7,688 | $202 |
| Imaging of retina | 164 | $7,517 | $31 |
| Removal of recurring cataract in lens capsule using a laser | 15 | $5,938 | $297 |
| Exam of visual field with extended testing | 117 | $5,686 | $49 |
| Imaging of optic nerve | 120 | $3,317 | $28 |
| Removal of eyelashes using forceps | 36 | $1,534 | $18 |
| Measurement of corneal curvature and depth of eye | 36 | $1,489 | $41 |
| Measurement of corneal curvature and depth of eye | 13 | $380 | $29 |
| Ultrasound scan of cornea to determine thickness | 29 | $255 | $9 |
2022: 17 services
| Established patient problem focused exam of visual system | 452 | $47,400 | $66 |
| Established patient complete exam of visual system | 387 | $44,263 | $95 |
| Removal of cataract with insertion of prosthetic lens | 39 | $30,499 | $508 |
| New patient complete exam of visual system | 185 | $14,907 | $81 |
| Imaging of retina | 198 | $10,700 | $32 |
| Injection of drug into eye | 28 | $8,515 | $98 |
| Closure of tear duct opening using plug | 23 | $7,097 | $177 |
| Exam of visual field with extended testing | 127 | $6,063 | $47 |
| Injection, bevacizumab, 10 mg | 26 | $4,089 | None |
| Removal of recurring cataract in lens capsule using a laser | 12 | $3,881 | $277 |
| Laser repair to improve eye fluid flow | 13 | $3,800 | $181 |
| Imaging of optic nerve | 119 | $3,290 | $28 |
| Removal of eyelashes using forceps | 42 | $1,695 | $18 |
| Measurement of corneal curvature and depth of eye | 42 | $1,691 | $40 |
| New patient visit (30+ min) | 16 | $1,126 | $70 |
| Measurement of corneal curvature and depth of eye | 23 | $691 | $29 |
| Ultrasound scan of cornea to determine thickness | 32 | $312 | $10 |
2021: 17 services
| Injection, aflibercept, 1 mg | 12 | $37,894 | None |
| Established patient problem focused exam of visual system | 302 | $36,666 | $75 |
| Established patient complete exam of visual system | 296 | $33,142 | $95 |
| Removal of cataract with insertion of prosthetic lens | 40 | $30,498 | $517 |
| New patient complete exam of visual system | 142 | $15,097 | $106 |
| Injection of drug into eye | 29 | $10,090 | $103 |
| Imaging of retina | 153 | $9,436 | $36 |
| Removal of recurring cataract in lens capsule using a laser | 17 | $6,337 | $317 |
| Exam of visual field with extended testing | 84 | $4,864 | $58 |
| Injection, bevacizumab, 10 mg | 26 | $3,871 | None |
| Imaging of optic nerve | 96 | $3,089 | $32 |
| Measurement of corneal curvature and depth of eye | 42 | $2,127 | $49 |
| Removal of eyelashes using forceps | 26 | $1,440 | $22 |
| New patient visit (30+ min) | 18 | $807 | $45 |
| Measurement of corneal curvature and depth of eye | 21 | $625 | $30 |
| Ultrasound scan of cornea to determine thickness | 34 | $369 | $11 |
| Exam of the internal drainage system of eye | 16 | $284 | $18 |
2020: 14 services
| Established patient complete exam of visual system | 260 | $28,528 | $93 |
| Established patient problem focused exam of visual system | 220 | $22,028 | $67 |
| Removal of cataract with insertion of prosthetic lens | 21 | $17,106 | $535 |
| Injection of drug into eye | 20 | $7,896 | $88 |
| Imaging of retina | 115 | $6,757 | $34 |
| New patient complete exam of visual system | 61 | $6,105 | $100 |
| Injection, bevacizumab, 10 mg | 20 | $4,905 | None |
| Exam of visual field with extended testing | 61 | $2,596 | $41 |
| Imaging of optic nerve | 56 | $1,809 | $31 |
| Removal of eyelashes using forceps | 26 | $1,341 | $27 |
| Measurement of corneal curvature and depth of eye | 17 | $1,103 | $65 |
| Photography of the retina | 15 | $602 | $38 |
| Measurement of corneal curvature and depth of eye | 15 | $453 | $30 |
| Ultrasound scan of cornea to determine thickness | 16 | $156 | $10 |
2019: 18 services
| Established patient problem focused exam of visual system | 424 | $44,034 | $71 |
| Removal of cataract with insertion of prosthetic lens | 45 | $42,266 | $622 |
| Established patient complete exam of visual system | 397 | $39,426 | $92 |
| Photography of the retina | 405 | $19,478 | $48 |
| New patient visit (45+ min) | 164 | $15,194 | $93 |
| Injection of drug into eye | 35 | $9,865 | $94 |
| Imaging of retina | 176 | $8,524 | $32 |
| New patient complete exam of visual system | 64 | $7,197 | $112 |
| Injection, bevacizumab, 10 mg | 31 | $5,543 | None |
| Exam of visual field with extended testing | 87 | $4,976 | $57 |
| Removal of recurring cataract in lens capsule using a laser | 16 | $4,403 | $275 |
| Measurement of corneal curvature and depth of eye | 40 | $2,778 | $68 |
| Imaging of optic nerve | 86 | $2,732 | $32 |
| Removal of eyelashes using forceps | 42 | $2,562 | $35 |
| Measurement of corneal curvature and depth of eye | 29 | $876 | $30 |
| New patient visit (30+ min) | 15 | $652 | $43 |
| Short return visit (20+ min) | 12 | $500 | $42 |
| Ultrasound scan of cornea to determine thickness | 29 | $290 | $10 |
2018: 21 services
| Injection, aflibercept, 1 mg | 17 | $64,070 | None |
| Established patient complete exam of visual system | 329 | $32,915 | $92 |
| Removal of cataract with insertion of prosthetic lens | 37 | $31,412 | $604 |
| Established patient problem focused exam of visual system | 328 | $27,872 | $63 |
| New patient visit (45+ min) | 188 | $22,439 | $119 |
| Photography of the retina | 326 | $18,601 | $57 |
| Injection of drug into eye | 29 | $9,002 | $90 |
| Return visit (30+ min) | 116 | $8,760 | $74 |
| Imaging of retina | 175 | $7,973 | $33 |
| Short return visit (20+ min) | 118 | $7,262 | $57 |
| New patient complete exam of visual system | 96 | $6,369 | $66 |
| Exam of visual field with extended testing | 88 | $4,730 | $54 |
| Creation of eye fluid drainage tracts in iris using a laser, per session | 11 | $4,079 | $227 |
| Measurement of corneal curvature and depth of eye | 46 | $3,492 | $74 |
| Injection, bevacizumab, 10 mg | 22 | $3,340 | None |
| Removal of eyelashes using forceps | 47 | $3,156 | $40 |
| Imaging of optic nerve | 88 | $2,880 | $33 |
| New patient visit (30+ min) | 26 | $1,706 | $66 |
| Ultrasound scan of cornea to determine thickness | 59 | $710 | $12 |
| Measurement of corneal curvature and depth of eye | 19 | $563 | $30 |
| Exam of the internal drainage system of eye | 21 | $439 | $21 |
2017: 16 services
| Established patient complete exam of visual system | 409 | $42,649 | $92 |
| Established patient problem focused exam of visual system | 419 | $38,037 | $63 |
| New patient complete exam of visual system | 279 | $28,316 | $101 |
| Removal of cataract with insertion of prosthetic lens | 32 | $19,902 | $569 |
| Injection of drug into eye | 20 | $9,426 | $89 |
| Injection, bevacizumab, 10 mg | 19 | $4,768 | None |
| Exam of visual field with extended testing | 79 | $4,420 | $56 |
| Imaging of retina | 88 | $4,153 | $33 |
| Removal of recurring cataract in lens capsule using a laser | 11 | $3,094 | $281 |
| Removal of eyelashes using forceps | 40 | $3,008 | $48 |
| Imaging of optic nerve | 79 | $2,557 | $32 |
| Measurement of corneal curvature and depth of eye | 30 | $2,522 | $84 |
| Photography of the retina | 23 | $1,472 | $64 |
| New patient problem focused exam of visual system | 20 | $1,093 | $55 |
| Exam of the internal drainage system of eye | 20 | $380 | $19 |
| Ultrasound scan of cornea to determine thickness | 25 | $322 | $13 |
2016: 15 services
| Established patient problem focused exam of visual system | 216 | $20,698 | $80 |
| Established patient complete exam of visual system | 145 | $16,645 | $110 |
| New patient complete exam of visual system | 108 | $12,972 | $120 |
| Removal of cataract with insertion of prosthetic lens | 12 | $9,103 | $607 |
| Short return visit (20+ min) | 67 | $4,348 | $61 |
| Injection of drug into eye | 15 | $4,231 | $94 |
| Imaging of retina | 62 | $2,883 | $40 |
| Return visit (30+ min) | 33 | $2,798 | $85 |
| Injection, bevacizumab, 10 mg | 15 | $2,487 | None |
| Exam of visual field with extended testing | 39 | $2,445 | $63 |
| New patient visit (45+ min) | 17 | $2,177 | $128 |
| Removal of eyelashes using forceps | 25 | $1,933 | $54 |
| Imaging of optic nerve | 41 | $1,638 | $40 |
| Measurement of corneal curvature and depth of eye | 13 | $1,191 | $92 |
| Exam of the internal drainage system of eye | 11 | $178 | $16 |
2015: 8 services
| New patient complete exam of visual system | 99 | $12,838 | $130 |
| Established patient complete exam of visual system | 87 | $9,942 | $109 |
| Established patient problem focused exam of visual system | 118 | $9,694 | $79 |
| Removal of eyelashes using forceps | 16 | $946 | $56 |
| Exam of visual field with extended testing | 11 | $710 | $65 |
| New patient problem focused exam of visual system | 11 | $651 | $59 |
| Imaging of retina | 12 | $528 | $44 |
| Imaging of optic nerve | 12 | $478 | $40 |
Medicaid work
$40,325 in 2024
Medicaid paid $40,325 for 2,787 billed services this clinician did in 2024, up to 119 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 338 | $13,419 |
| New patient visit (45+ min) | 203 | $10,845 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 933 | $5,451 |
| Return visit (30+ min) | 81 | $2,527 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 231 | $2,258 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 221 | $1,657 |
| New patient visit (30+ min) | 495 | $1,496 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 160 | $1,469 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 113 | $1,087 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 12 | $117 |
| 2024 | 2,787 | 10 | 119 | $40,325 |
| 2023 | 3,994 | 14 | 141 | $44,245 |
| 2022 | 3,520 | 14 | 123 | $25,036 |
| 2021 | 2,446 | 13 | 86 | $21,796 |
| 2020 | 1,500 | 11 | 56 | $11,199 |
| 2019 | 2,504 | 12 | 102 | $14,572 |
| 2018 | 1,634 | 14 | 65 | $10,864 |
See the largest Medicaid services in earlier years
2023
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 1,234 | $12,081 |
| Short return visit (20+ min) | 327 | $6,679 |
| New patient visit (45+ min) | 369 | $4,259 |
| New patient visit (30+ min) | 431 | $4,222 |
| Return visit (30+ min) | 163 | $3,938 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 412 | $3,800 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 291 | $2,887 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 329 | $1,955 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 222 | $1,717 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 38 | $923 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 16 | $859 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 72 | $642 |
2022
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 1,198 | $9,901 |
| New patient visit (30+ min) | 348 | $2,757 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 375 | $2,533 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 269 | $2,172 |
| Intravitreal injection of a pharmacologic agent (separate procedure) | 47 | $1,451 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 269 | $1,261 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 96 | $1,184 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 259 | $1,026 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 52 | $794 |
| New patient visit (45+ min) | 367 | $774 |
| Injection, bevacizumab, 10 mg | 44 | $576 |
| Short return visit (20+ min) | 84 | $503 |
2021
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 817 | $5,576 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 49 | $3,955 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 230 | $3,041 |
| Intravitreal injection of a pharmacologic agent (separate procedure) | 111 | $2,926 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 327 | $1,733 |
| New patient visit (30+ min) | 339 | $1,594 |
| Injection, bevacizumab, 10 mg | 73 | $712 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 133 | $555 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 83 | $517 |
| New patient visit (45+ min) | 97 | $505 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 135 | $408 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 13 | $226 |
2020
| Intravitreal injection of a pharmacologic agent (separate procedure) | 86 | $2,773 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 423 | $2,110 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 144 | $1,487 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 198 | $981 |
| New patient visit (30+ min) | 247 | $970 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 95 | $847 |
| Return visit (30+ min) | 85 | $661 |
| Injection, bevacizumab, 10 mg | 55 | $560 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 91 | $551 |
| New patient visit (45+ min) | 64 | $228 |
| Ophthalmic ultrasound, diagnostic; corneal pachymetry, unilateral or bilateral (determination of corneal thickness) | 12 | $31 |
2019
| New patient visit (45+ min) | 289 | $2,887 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 49 | $2,452 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 351 | $2,237 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 194 | $1,966 |
| Short return visit (20+ min) | 150 | $1,468 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 568 | $1,313 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 185 | $1,133 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 86 | $576 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 58 | $251 |
| New patient visit (30+ min) | 447 | $248 |
| Ophthalmic biometry by partial coherence interferometry with intraocular lens power calculation | 54 | $41 |
| Low risk for retinopathy (no evidence of retinopathy in the prior year) (DM) | 73 | $0 |
2018
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 245 | $3,009 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 72 | $1,552 |
| FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT | 339 | $917 |
| Intravitreal injection of a pharmacologic agent (separate procedure) | 32 | $908 |
| Short return visit (20+ min) | 99 | $825 |
| New patient visit (45+ min) | 150 | $788 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 102 | $619 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 16 | $596 |
| XCAPSL CTRC RMVL INSJ IO LENS PROSTH W/O ECP | 12 | $471 |
| Visual field examination, unilateral or bilateral, with interpretation and report; extended examination (eg, Goldmann visual fields with at least 3 isopters plotted and static determination within the central 30°, or quantitative, automated threshold perimetry, Octopus program G-1, 32 or 42, Humphrey visual field analyzer full threshold programs 30-2, 24-2, or 30/60-2) | 41 | $422 |
| New patient visit (30+ min) | 473 | $378 |
| Injection, bevacizumab, 10 mg | 13 | $235 |
Drugs they prescribed that Part D paid
$1,103,561
Pharmacies billed $1,103,561 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 4,893) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
2,332 generic and 2,561 brand-name prescriptions · $1,103,561 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Restasis | 371 | $382,774 | $1,032 |
| Lumigan | 471 | $177,479 | $377 |
| Cyclosporine | 193 | $117,313 | $608 |
| Xiidra | 46 | $59,460 | $1,293 |
| Cequa | 68 | $59,390 | $873 |
See all 29 drugs
| Restasis | 371 | $382,774 | $1,032 |
| Lumigan | 471 | $177,479 | $377 |
| Cyclosporine | 193 | $117,313 | $608 |
| Xiidra | 46 | $59,460 | $1,293 |
| Cequa | 68 | $59,390 | $873 |
| Brimonidine | 276 | $47,409 | $172 |
| Alphagan P | 98 | $29,196 | $298 |
| Simbrinza | 105 | $23,395 | $223 |
| Rhopressa | 58 | $22,272 | $384 |
| Eysuvis | 37 | $19,195 | $519 |
| Rocklatan | 30 | $14,748 | $492 |
| Latanoprost | 958 | $12,764 | $13 |
| Combigan | 28 | $12,058 | $431 |
| Azelastine | 664 | $11,820 | $18 |
| Brinzolamide | 55 | $11,184 | $203 |
| Travoprost | 62 | $10,472 | $169 |
| Brimonidine Tartrate-Timolol | 64 | $9,463 | $148 |
| Azopt | 19 | $9,123 | $480 |
| Prednisolone Acetate | 313 | $8,762 | $28 |
| Tyrvaya | 13 | $8,649 | $665 |
| Vyzulta | 20 | $6,393 | $320 |
| Moxifloxacin | 219 | $4,649 | $21 |
| Diclofenac | 223 | $2,170 | $10 |
| Dorzolamide-Timolol | 105 | $1,589 | $15 |
| Erythromycin | 121 | $1,257 | $10 |
| Timolol Maleate | 111 | $1,140 | $10 |
| Dorzolamide | 25 | $481 | $19 |
| Tobramycin-Dexamethasone | 13 | $356 | $27 |
| Neomycin-Polymyxin-Dexameth | 13 | $131 | $10 |
Year by year
| 2024 | 4,893 | 852 | 0% (0) | 52% | $1,103,561 |
| 2023 | 4,911 | 909 | 0% (0) | 54% | $1,269,289 |
| 2022 | 4,992 | 960 | 0% (0) | 54% | $1,201,363 |
| 2021 | 4,324 | 750 | 0% (0) | 55% | $797,836 |
| 2020 | 4,231 | 652 | 0% (0) | 54% | $722,977 |
| 2019 | 4,635 | 836 | 0% (0) | 57% | $699,878 |
| 2018 | 5,050 | 946 | 0% (0) | 58% | $732,464 |
| 2017 | 4,122 | 858 | 0% (0) | 54% | $497,985 |
| 2016 | 2,598 | 626 | 0% (0) | 60% | $296,152 |
| 2015 | 630 | 258 | 6% (36) | 54% | $57,671 |
| 2014 | 183 | 84 | None | 39% | $8,545 |
| 2013 | 37 | 12 | 0% (0) | 51% | $7,384 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 33 drugs
| Restasis | 348 | $443,706 | $1,275 |
| Lumigan | 410 | $173,444 | $423 |
| Alphagan P | 291 | $96,661 | $332 |
| Cyclosporine | 99 | $66,119 | $668 |
| Xiidra | 30 | $53,694 | $1,790 |
| Cequa | 50 | $52,129 | $1,043 |
| Azopt | 63 | $36,377 | $577 |
| Eysuvis | 56 | $30,325 | $542 |
| Latanoprost | 1,085 | $26,405 | $24 |
| Simbrinza | 97 | $25,077 | $259 |
| Rhopressa | 43 | $22,960 | $534 |
| Combigan | 61 | $21,546 | $353 |
| Rocklatan | 31 | $21,517 | $694 |
| Tyrvaya | 32 | $21,205 | $663 |
| Brimonidine | 108 | $19,663 | $182 |
| Azelastine | 541 | $19,269 | $36 |
| Travoprost | 85 | $18,838 | $222 |
| Brinzolamide | 51 | $15,623 | $306 |
| Brimonidine Tartrate-Timolol | 38 | $13,400 | $353 |
| Zerviate | 17 | $12,359 | $727 |
| Prednisolone Acetate | 281 | $10,273 | $37 |
| Moxifloxacin | 178 | $7,111 | $40 |
| Besivance | 23 | $5,155 | $224 |
| Olopatadine | 111 | $4,534 | $41 |
| Lotemax Sm | 16 | $4,483 | $280 |
| Ilevro | 12 | $4,449 | $371 |
| Dorzolamide-Timolol | 128 | $4,440 | $35 |
| Loteprednol Etabonate | 14 | $3,199 | $228 |
| Diclofenac | 183 | $2,532 | $14 |
| Erythromycin | 160 | $2,091 | $13 |
| Timolol Maleate | 111 | $1,636 | $15 |
| Dorzolamide | 25 | $939 | $38 |
| Neomycin-Polymyxin-Dexameth | 39 | $518 | $13 |
2022: 36 drugs
| Restasis | 375 | $475,563 | $1,268 |
| Lumigan | 363 | $143,299 | $395 |
| Alphagan P | 293 | $86,212 | $294 |
| Cequa | 66 | $60,242 | $913 |
| Xiidra | 49 | $43,586 | $890 |
| Cyclosporine | 52 | $34,428 | $662 |
| Azopt | 59 | $31,333 | $531 |
| Rhopressa | 53 | $29,174 | $550 |
| Azelastine | 572 | $26,266 | $46 |
| Combigan | 70 | $22,323 | $319 |
| Travoprost | 87 | $21,961 | $252 |
| Latanoprost | 1,072 | $21,741 | $20 |
| Eysuvis | 38 | $18,988 | $500 |
| Brimonidine Tartrate-Timolol | 71 | $17,747 | $250 |
| Rocklatan | 29 | $17,536 | $605 |
| Simbrinza | 50 | $14,923 | $298 |
| Brimonidine | 75 | $14,493 | $193 |
| Prednisolone Acetate | 320 | $14,038 | $44 |
| Brinzolamide | 37 | $12,060 | $326 |
| Prolensa | 31 | $10,049 | $324 |
| Ilevro | 24 | $7,698 | $321 |
| Moxifloxacin | 230 | $7,329 | $32 |
| Olopatadine | 127 | $6,862 | $54 |
| Zerviate | 16 | $5,553 | $347 |
| Lotemax Sm | 23 | $5,290 | $230 |
| Besivance | 25 | $5,254 | $210 |
| Zioptan | 11 | $5,220 | $475 |
| Dorzolamide-Timolol | 130 | $4,957 | $38 |
| Diclofenac | 204 | $3,889 | $19 |
| Loteprednol Etabonate | 20 | $3,636 | $182 |
| Erythromycin | 157 | $1,980 | $13 |
| Tobramycin-Dexamethasone | 14 | $1,330 | $95 |
| Timolol Maleate | 95 | $1,189 | $13 |
| Dorzolamide | 25 | $971 | $39 |
| Neomycin-Polymyxin-Dexameth | 36 | $594 | $16 |
| Acyclovir | 13 | $212 | $16 |
2021: 30 drugs
| Restasis | 281 | $254,342 | $905 |
| Lumigan | 359 | $121,216 | $338 |
| Alphagan P | 285 | $86,213 | $303 |
| Combigan | 185 | $49,739 | $269 |
| Azopt | 62 | $31,560 | $509 |
| Cequa | 40 | $23,898 | $597 |
| Xiidra | 25 | $21,661 | $866 |
| Rhopressa | 53 | $20,545 | $388 |
| Travoprost | 78 | $18,880 | $242 |
| Latanoprost | 956 | $16,385 | $17 |
| Brimonidine | 91 | $15,409 | $169 |
| Azelastine | 442 | $14,615 | $33 |
| Olopatadine | 224 | $12,841 | $57 |
| Zerviate | 42 | $12,024 | $286 |
| Inveltys | 41 | $11,911 | $291 |
| Prolensa | 39 | $11,905 | $305 |
| Prednisolone Acetate | 241 | $10,255 | $43 |
| Rocklatan | 17 | $7,257 | $427 |
| Brinzolamide | 18 | $7,109 | $395 |
| Besivance | 33 | $6,325 | $192 |
| Moxifloxacin | 175 | $5,537 | $32 |
| Dorzolamide-Timolol | 122 | $5,438 | $45 |
| Simbrinza | 14 | $4,662 | $333 |
| Diclofenac | 156 | $2,852 | $18 |
| Flarex | 18 | $2,323 | $129 |
| Tobramycin-Dexamethasone | 18 | $1,374 | $76 |
| Erythromycin | 100 | $1,305 | $13 |
| Timolol Maleate | 77 | $1,096 | $14 |
| Dorzolamide | 17 | $713 | $42 |
| Neomycin-Polymyxin-Dexameth | 12 | $216 | $18 |
2020: 33 drugs
| Restasis | 339 | $256,952 | $758 |
| Alphagan P | 259 | $66,462 | $257 |
| Lumigan | 220 | $63,586 | $289 |
| Combigan | 147 | $37,809 | $257 |
| Azopt | 95 | $37,434 | $394 |
| Travoprost | 207 | $35,510 | $172 |
| Rhopressa | 102 | $28,770 | $282 |
| Travatan Z | 108 | $26,858 | $249 |
| Xiidra | 30 | $19,682 | $656 |
| Pazeo | 63 | $14,051 | $223 |
| Latanoprost | 876 | $12,076 | $14 |
| Cequa | 20 | $10,697 | $535 |
| Zerviate | 37 | $10,227 | $276 |
| Olopatadine | 272 | $10,025 | $37 |
| Rocklatan | 21 | $7,718 | $368 |
| Dorzolamide-Timolol | 153 | $7,401 | $48 |
| Prolensa | 26 | $7,331 | $282 |
| Prednisolone Acetate | 177 | $7,261 | $41 |
| Azelastine | 335 | $7,219 | $22 |
| Brimonidine | 135 | $6,750 | $50 |
| Ilevro | 22 | $6,331 | $288 |
| Simbrinza | 23 | $4,926 | $214 |
| Moxifloxacin | 92 | $3,919 | $43 |
| Besivance | 19 | $3,457 | $182 |
| Lotemax | 11 | $2,759 | $251 |
| Tobramycin-Dexamethasone | 28 | $2,430 | $87 |
| Diclofenac | 72 | $1,551 | $22 |
| Flarex | 13 | $1,205 | $93 |
| Bacitracin | 12 | $1,031 | $86 |
| Erythromycin | 74 | $900 | $12 |
| Timolol Maleate | 85 | $742 | $9 |
| Dorzolamide | 19 | $706 | $37 |
| Tobramycin | 25 | $278 | $11 |
2019: 35 drugs
| Restasis | 302 | $227,992 | $755 |
| Travatan Z | 462 | $102,757 | $222 |
| Alphagan P | 253 | $62,807 | $248 |
| Combigan | 156 | $34,826 | $223 |
| Azopt | 107 | $34,276 | $320 |
| Lumigan | 117 | $32,306 | $276 |
| Lotemax | 105 | $21,283 | $203 |
| Rhopressa | 64 | $19,036 | $297 |
| Olopatadine | 293 | $17,614 | $60 |
| Pazeo | 83 | $16,326 | $197 |
| Prolensa | 55 | $14,575 | $265 |
| Azelastine | 385 | $13,230 | $34 |
| Latanoprost | 918 | $11,262 | $12 |
| Xiidra | 15 | $10,307 | $687 |
| Prednisolone Acetate | 225 | $10,264 | $46 |
| Brimonidine | 184 | $8,431 | $46 |
| Ilevro | 24 | $6,508 | $271 |
| Besivance | 32 | $5,398 | $169 |
| Simbrinza | 28 | $5,037 | $180 |
| Dorzolamide-Timolol | 126 | $4,721 | $37 |
| Zioptan | 16 | $4,093 | $256 |
| Tobramycin-Dexamethasone | 35 | $3,040 | $87 |
| Tobradex | 13 | $3,031 | $233 |
| Durezol | 14 | $2,623 | $187 |
| Moxifloxacin | 56 | $2,156 | $39 |
| Diclofenac | 95 | $1,550 | $16 |
| Bacitracin | 17 | $1,533 | $90 |
| Tobramycin | 81 | $872 | $11 |
| Timolol Maleate | 110 | $787 | $7 |
| Erythromycin | 60 | $742 | $12 |
| Dorzolamide | 30 | $722 | $24 |
| Levofloxacin | 11 | $578 | $53 |
| Ketorolac Tromethamine | 30 | $478 | $16 |
| Ciprofloxacin | 23 | $268 | $12 |
| Cromolyn | 11 | $129 | $12 |
2018: 33 drugs
| Restasis | 422 | $277,441 | $657 |
| Travatan Z | 556 | $124,505 | $224 |
| Azopt | 152 | $47,817 | $315 |
| Alphagan P | 206 | $45,550 | $221 |
| Olopatadine | 418 | $32,626 | $78 |
| Lotemax | 134 | $26,475 | $198 |
| Combigan | 99 | $18,282 | $185 |
| Pazeo | 86 | $15,540 | $181 |
| Brimonidine | 267 | $14,911 | $56 |
| Prednisolone Acetate | 318 | $14,832 | $47 |
| Azelastine | 436 | $13,985 | $32 |
| Restasis Multidose | 18 | $13,541 | $752 |
| Prolensa | 51 | $12,770 | $250 |
| Lumigan | 44 | $11,834 | $269 |
| Latanoprost | 925 | $10,880 | $12 |
| Xiidra | 18 | $9,050 | $503 |
| Besivance | 27 | $4,293 | $159 |
| Tobradex | 17 | $3,938 | $232 |
| Dorzolamide-Timolol | 110 | $3,461 | $31 |
| Simbrinza | 17 | $2,809 | $165 |
| Moxifloxacin | 57 | $2,677 | $47 |
| Rhopressa | 11 | $2,665 | $242 |
| Levofloxacin | 43 | $2,542 | $59 |
| Tobramycin-Dexamethasone | 30 | $2,230 | $74 |
| Timolol Maleate | 147 | $1,558 | $11 |
| Bacitracin | 11 | $1,473 | $134 |
| Erythromycin | 82 | $1,009 | $12 |
| Diclofenac | 50 | $995 | $20 |
| Dorzolamide | 40 | $932 | $23 |
| Ketorolac Tromethamine | 41 | $885 | $22 |
| Tobramycin | 73 | $835 | $11 |
| Ciprofloxacin | 38 | $437 | $11 |
| Neomycin-Polymyxin-Dexameth | 20 | $335 | $17 |
2017: 34 drugs
| Restasis | 268 | $139,636 | $521 |
| Travatan Z | 445 | $87,768 | $197 |
| Azopt | 110 | $34,583 | $314 |
| Pataday | 152 | $25,832 | $170 |
| Lotemax | 125 | $24,308 | $194 |
| Olopatadine | 208 | $19,445 | $93 |
| Alphagan P | 97 | $19,403 | $200 |
| Lumigan | 85 | $18,285 | $215 |
| Prednisolone Acetate | 283 | $14,007 | $49 |
| Prolensa | 52 | $12,055 | $232 |
| Azelastine | 348 | $11,788 | $34 |
| Xiidra | 24 | $11,161 | $465 |
| Combigan | 70 | $11,029 | $158 |
| Brimonidine | 207 | $8,473 | $41 |
| Latanoprost | 662 | $7,797 | $12 |
| Pazeo | 35 | $6,303 | $180 |
| Vigamox | 33 | $5,191 | $157 |
| Besivance | 33 | $4,909 | $149 |
| Dorzolamide-Timolol | 189 | $4,799 | $25 |
| Tobradex | 16 | $3,428 | $214 |
| Tobramycin-Dexamethasone | 33 | $3,017 | $91 |
| Bacitracin | 23 | $2,036 | $89 |
| Diclofenac | 98 | $1,597 | $16 |
| Erythromycin | 83 | $1,101 | $13 |
| Moxifloxacin | 15 | $1,077 | $72 |
| Timolol Maleate | 106 | $932 | $9 |
| Fluorometholone | 14 | $925 | $66 |
| Levofloxacin | 16 | $852 | $53 |
| Dorzolamide | 31 | $654 | $21 |
| Ciprofloxacin | 50 | $550 | $11 |
| Neomycin-Polymyxin-Dexameth | 33 | $546 | $17 |
| Tobramycin | 53 | $505 | $10 |
| Ketorolac Tromethamine | 33 | $424 | $13 |
| Acyclovir | 17 | $215 | $13 |
2016: 28 drugs
| Restasis | 134 | $65,807 | $491 |
| Travatan Z | 227 | $41,879 | $184 |
| Azopt | 86 | $24,251 | $282 |
| Lotemax | 124 | $23,183 | $187 |
| Pataday | 120 | $22,135 | $184 |
| Lumigan | 70 | $12,207 | $174 |
| Vigamox | 73 | $11,372 | $156 |
| Prednisolone Acetate | 201 | $11,042 | $55 |
| Alphagan P | 62 | $10,692 | $172 |
| Prolensa | 49 | $10,575 | $216 |
| Combigan | 49 | $7,575 | $155 |
| Azelastine | 124 | $6,304 | $51 |
| Tobramycin-Dexamethasone | 66 | $6,094 | $92 |
| Latanoprost | 375 | $4,829 | $13 |
| Durezol | 24 | $4,052 | $169 |
| Brimonidine | 87 | $3,616 | $42 |
| Besivance | 26 | $3,559 | $137 |
| Olopatadine | 43 | $3,080 | $72 |
| Dorzolamide-Timolol | 99 | $2,218 | $22 |
| Diclofenac | 122 | $1,899 | $16 |
| Bacitracin | 17 | $1,645 | $97 |
| Timolol Maleate | 84 | $1,168 | $14 |
| Erythromycin | 89 | $1,129 | $13 |
| Fluorometholone | 15 | $910 | $61 |
| Neomycin-Polymyxin-Dexameth | 30 | $555 | $19 |
| Tobramycin | 46 | $487 | $11 |
| Dorzolamide | 20 | $432 | $22 |
| Ciprofloxacin | 29 | $372 | $13 |
2015: 19 drugs
| Lotemax | 36 | $6,946 | $193 |
| Pataday | 34 | $5,457 | $160 |
| Vigamox | 31 | $4,388 | $142 |
| Azopt | 15 | $3,788 | $253 |
| Prednisolone Acetate | 57 | $3,636 | $64 |
| Patanol | 14 | $3,363 | $240 |
| Travatan Z | 19 | $3,228 | $170 |
| Lumigan | 15 | $3,168 | $211 |
| Ilevro | 11 | $2,521 | $229 |
| Durezol | 12 | $1,866 | $156 |
| Combigan | 11 | $1,414 | $129 |
| Tobramycin-Dexamethasone | 14 | $1,289 | $92 |
| Latanoprost | 75 | $1,171 | $16 |
| Brimonidine | 32 | $1,127 | $35 |
| Erythromycin | 49 | $640 | $13 |
| Dorzolamide-Timolol | 23 | $565 | $25 |
| Diclofenac | 28 | $559 | $20 |
| Hydrocodone-Acetaminophen | 31 | $266 | $9 |
| Timolol Maleate | 22 | $255 | $12 |
2014: 5 drugs
| Prednisolone Acetate | 44 | $2,363 | $54 |
| Ketorolac Tromethamine | 23 | $307 | $13 |
| Dorzolamide-Timolol | 12 | $293 | $24 |
| Latanoprost | 13 | $291 | $22 |
| Ofloxacin | 27 | $239 | $9 |
Money from drug and device companies
$1,167 in 2025
| 2025 | 7 | 64 | None | $1,167 |
| 2024 | 11 | 45 | None | $1,017 |
| 2023 | 12 | 52 | None | $1,498 |
| 2022 | 11 | 62 | None | $1,265 |
| 2021 | 11 | 52 | None | $910 |
| 2020 | 9 | 54 | None | $690 |
| 2019 | 14 | 44 | None | $1,185 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Tarsus Pharmaceuticals | Xdemvy | $294 | 29 payments
|
| Abbvie | Lumigan | $258 | 9 payments
|
| Alcon Vision | Rocklatan | $202 | 9 payments
|
| Bausch & Lomb Americas | Miebo | $195 | 9 payments
|
| Sun Pharmaceutical Industries | Cequa | $86 | 3 payments
|
| Oyster Point Pharma | Tyrvaya | $77 | 3 payments
|
See all 64 published payments
| Bausch & Lomb Americas | Meals · 2025-12-19 | Miebo | $22 |
| Tarsus Pharmaceuticals | Meals · 2025-12-12 | Xdemvy | $7 |
| Tarsus Pharmaceuticals | Meals · 2025-12-03 | None | $5 |
| Tarsus Pharmaceuticals | Meals · 2025-12-03 | Xdemvy | $22 |
| Tarsus Pharmaceuticals | Meals · 2025-11-24 | Xdemvy | $8 |
| Oyster Point Pharma | Meals · 2025-11-17 | Tyrvaya | $23 |
| Tarsus Pharmaceuticals | Meals · 2025-11-12 | Xdemvy | $9 |
| Alcon Vision | Meals · 2025-11-04 | Eysuvis | $11 |
| Bausch & Lomb Americas | Meals · 2025-10-31 | Vyzulta | $23 |
| Abbvie | Meals · 2025-10-30 | Lumigan | $34 |
| Tarsus Pharmaceuticals | Meals · 2025-10-29 | Xdemvy | $9 |
| Tarsus Pharmaceuticals | Meals · 2025-10-22 | Xdemvy | $8 |
| Bausch & Lomb Americas | Meals · 2025-10-22 | Miebo | $24 |
| Sun Pharmaceutical Industries | Meals · 2025-10-16 | Cequa | $24 |
| Alcon Vision | Meals · 2025-10-10 | Clareon Panoptix Pro | $28 |
| Bausch & Lomb Americas | Meals · 2025-10-08 | Vyzulta | $10 |
| Tarsus Pharmaceuticals | Meals · 2025-10-03 | Xdemvy | $8 |
| Amgen | Meals · 2025-10-01 | Tepezza | $27 |
| Tarsus Pharmaceuticals | Meals · 2025-09-24 | Xdemvy | $8 |
| Alcon Vision | Meals · 2025-09-23 | Tryptyr | $32 |
| Tarsus Pharmaceuticals | Meals · 2025-09-17 | Xdemvy | $8 |
| Abbvie | Meals · 2025-09-16 | Lumigan | $30 |
| Tarsus Pharmaceuticals | Meals · 2025-09-09 | Xdemvy | $8 |
| Sun Pharmaceutical Industries | Meals · 2025-09-09 | Cequa | $32 |
| Tarsus Pharmaceuticals | Meals · 2025-09-03 | Xdemvy | $8 |
| Oyster Point Pharma | Meals · 2025-08-28 | Tyrvaya | $22 |
| Tarsus Pharmaceuticals | Meals · 2025-08-27 | Xdemvy | $9 |
| Bausch & Lomb Americas | Meals · 2025-08-26 | Miebo | $23 |
| Abbvie | Meals · 2025-08-21 | Lumigan | $31 |
| Tarsus Pharmaceuticals | Meals · 2025-08-20 | Xdemvy | $8 |
| Tarsus Pharmaceuticals | Meals · 2025-08-13 | Xdemvy | $7 |
| Tarsus Pharmaceuticals | Meals · 2025-07-30 | Xdemvy | $8 |
| Tarsus Pharmaceuticals | Meals · 2025-07-22 | Xdemvy | $8 |
| Tarsus Pharmaceuticals | Meals · 2025-07-16 | Xdemvy | $8 |
| Abbvie | Meals · 2025-07-09 | Lumigan | $29 |
| Tarsus Pharmaceuticals | Meals · 2025-07-09 | Xdemvy | $8 |
| Alcon Vision | Meals · 2025-07-02 | Eysuvis | $25 |
| Bausch & Lomb Americas | Meals · 2025-07-01 | Miebo | $23 |
| Bausch & Lomb Americas | Meals · 2025-07-01 | Vyzulta | $20 |
| Tarsus Pharmaceuticals | Meals · 2025-06-18 | Xdemvy | $24 |
| Abbvie | Meals · 2025-06-11 | Lumigan | $28 |
| Tarsus Pharmaceuticals | Meals · 2025-06-11 | Xdemvy | $8 |
| Tarsus Pharmaceuticals | Meals · 2025-06-04 | Xdemvy | $8 |
| Alcon Vision | Meals · 2025-06-03 | Rocklatan | $23 |
| Tarsus Pharmaceuticals | Meals · 2025-05-28 | Xdemvy | $8 |
| Tarsus Pharmaceuticals | Meals · 2025-05-21 | Xdemvy | $8 |
| Sun Pharmaceutical Industries | Meals · 2025-05-15 | Cequa | $30 |
| Tarsus Pharmaceuticals | Meals · 2025-05-14 | Xdemvy | $8 |
| Abbvie | Meals · 2025-05-01 | Lumigan | $29 |
| Tarsus Pharmaceuticals | Meals · 2025-04-30 | Xdemvy | $7 |
| Alcon Vision | Meals · 2025-04-23 | Rocklatan | $18 |
| Tarsus Pharmaceuticals | Meals · 2025-04-23 | Xdemvy | $27 |
| Bausch & Lomb Americas | Meals · 2025-04-23 | Miebo | $25 |
| Abbvie | Meals · 2025-04-08 | Lumigan | $30 |
| Tarsus Pharmaceuticals | Meals · 2025-04-02 | Xdemvy | $8 |
| Amgen | Meals · 2025-03-10 | Tepezza | $29 |
| Alcon Vision | Meals · 2025-03-05 | Hydrus Microstent | $24 |
| Bausch & Lomb Americas | Meals · 2025-02-27 | Miebo | $25 |
| Oyster Point Pharma | Meals · 2025-02-26 | Tyrvaya | $32 |
| Abbvie | Meals · 2025-02-22 | Lumigan | $34 |
| Alcon Vision | Meals · 2025-02-22 | Rocklatan | $10 |
| Alcon Vision | Meals · 2025-01-22 | Rocklatan | $31 |
| Tarsus Pharmaceuticals | Meals · 2025-01-15 | Xdemvy | $25 |
| Abbvie | Meals · 2025-01-09 | Lumigan | $12 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,017
| Abbvie | Lumigan | $213 | 9 payments
|
| Bausch & Lomb Americas | Miebo | $194 | 12 payments
|
| Biotissue Holdings | None | $159 | 6 payments
|
| Sun Pharmaceutical Industries | Cequa | $121 | 5 payments
|
| Amgen | Tepezza | $102 | 4 payments
|
| Alcon Vision | Rocklatan | $65 | 3 payments
|
| Mallinckrodt Hospital Products | Acthar | $60 | 2 payments
|
| Oyster Point Pharma | Tyrvaya | $32 | 1 payment
|
| Sight Sciences | Omni Surgical System | $25 | 1 payment
|
| Dompe US | Oxervate | $25 | 1 payment
|
| Thea Pharma | Iyuzeh | $20 | 1 payment
|
2023: $1,498
| Carl Zeiss Meditec USA | Lumera 700 | $378 | 2 payments
|
| Oyster Point Pharma | Tyrvaya | $294 | 9 payments
|
| Sun Pharmaceutical Industries | Cequa | $240 | 16 payments
|
| Alcon Vision | Rocklatan | $160 | 8 payments
|
| AbbVie | Lumigan | $155 | 5 payments
|
| Bausch & Lomb Americas | Vyzulta | $91 | 4 payments
|
| Horizon Therapeutics plc | Tepezza | $49 | 2 payments
|
| Thea Pharma | Iyuzeh | $46 | 2 payments
|
| Sight Sciences | Omni Surgical System | $25 | 1 payment
|
| Biotissue Holdings | Prokera | $21 | 1 payment
|
| Novartis Pharmaceuticals | Xiidra | $21 | 1 payment
|
| RxSight | Rxsight Contact Lens | $18 | 1 payment
|
2022: $1,265
| Oyster Point Pharma | Tyrvaya | $278 | 9 payments
|
| Sun Pharmaceutical Industries | Cequa | $223 | 11 payments
|
| Abbvie | Durysta | $185 | 10 payments
|
| Novartis Pharmaceuticals | Xiidra | $155 | 12 payments
|
| Alcon Vision | Rhopressa | $114 | 5 payments
|
| Bausch & Lomb Americas | Vyzulta | $109 | 5 payments
|
| Kala Pharmaceuticals | Inveltys | $62 | 3 payments
|
| Horizon Therapeutics plc | Tepezza | $58 | 3 payments
|
| Eyevance Pharmaceuticals | Flarex | $40 | 2 payments
|
| Dompe US | Oxervate | $25 | 1 payment
|
| Glaukos | Iaccess | $15 | 1 payment
|
2021: $910
| Aerie Pharmaceuticals | Rocklatan | $176 | 5 payments
|
| Allergan | Durysta | $129 | 10 payments
|
| Eyevance Pharmaceuticals | Tobradex St | $121 | 16 payments
|
| Sun Pharmaceutical Industries | Cequa | $89 | 4 payments
|
| Bausch & Lomb a division of Bausch Health US | Vyzulta | $87 | 4 payments
|
| Kala Pharmaceuticals | Inveltys | $81 | 3 payments
|
| Novartis Pharmaceuticals | Xiidra | $66 | 3 payments
|
| Tissuetech | Prokera | $64 | 3 payments
|
| Sight Sciences | Omni(R) Surgical System (US) | $54 | 2 payments
|
| Johnson & Johnson Surgical Vision | None | $23 | 1 payment
|
| Ivantis | Hydrus Microstent | $21 | 1 payment
|
2020: $690
| Sun Pharmaceutical Industries | Cequa | $187 | 16 payments
|
| Eyevance Pharmaceuticals | Flarex | $170 | 22 payments
|
| Allergan | Durysta | $80 | 4 payments
|
| Aerie Pharmaceuticals | Rocklatan | $70 | 3 payments
|
| Novartis Pharmaceuticals | Xiidra | $60 | 3 payments
|
| Bausch & Lomb a division of Bausch Health US | Lotemax Sm | $49 | 2 payments
|
| Kala Pharmaceuticals | Inveltys | $25 | 1 payment
|
| Ivantis | Hydrus | $25 | 1 payment
|
| TissueTech | Prokera | $24 | 2 payments
|
2019: $1,185
| Allergan | Restasis | $224 | 13 payments
|
| Sun Pharmaceutical Industries | Cequa | $196 | 9 payments
|
| Novartis Pharmaceuticals | Xiidra | $186 | 4 payments
|
| Alexion Pharmaceuticals | Soliris | $125 | 1 payment
|
| Hoffmann-La Roche | Non-Covered Product | $107 | 1 payment
|
| Aerie Pharmaceuticals | Rhopressa | $79 | 4 payments
|
| Bausch & Lomb a division of Bausch Health US | Vyzulta | $78 | 4 payments
|
| Shire North American Group | Xiidra | $45 | 2 payments
|
| TissueTech | Prokera | $44 | 1 payment
|
| Johnson & Johnson Surgical Vision | None | $27 | 1 payment
|
| Regeneron Healthcare Solutions | Eylea | $25 | 1 payment
|
| Alcon Vision | Restor | $22 | 1 payment
|
| Eyevance Pharmaceuticals | Flarex | $18 | 1 payment
|
| New World Medical | Ahmed Glaucoma Valve | $9 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1972861664
- Licence
- CA UNKNOWN
- Trained
- University of Southern California Keck School of Medicine, 2011
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 200 Jose Figueres Ave, Suite 350, San Jose, CA, 95116
- NPI first listed
- 2012-05-01
- NPI last updated
- 2015-09-02
This is when the NPI record was last certified, not a medical board exam.